The Emerging Role of Molecular Testing in Non–Small Cell Lung Cancer

Although this activity has expired, you may still view the supplement content. However, you will not be able to obtain CE credit.

This CME/CEU accredited supplement is jointly provided by:

hme logo

JADPRO 5 Fig02

JADPRO 5 Fig03

Faculty

Liang Cheng, MD, Indiana University School of Medicine 

Gregory Durm, MD, Indiana University Simon Cancer Center—IU Health

Patrick J. Kiel, PharmD, BCPS, BCOP, Indiana University School of Medicine, Indiana University Simon Cancer Center—IU Health

Anna Livers-Ertel, ANP-BC, MSN, OCN®, Franciscan Health Cancer Center

This supplement is supported by an educational grant from AstraZeneca.


Editorial

The Rise of Genetic Testing in Managing Patients With Non–Small Cell Lung Cancer

Patrick J. Kiel, PharmD, BCPS, BCOP

Read More
Review Article

The Emerging Role of Molecular Testing in Non–Small Cell Lung Cancer

Patrick J. Kiel,(1),(2) PharmD, BCPS, BCOP, Liang Cheng,(1) MD, Anna Livers-Ertel,(3) ANP-BC, MSN, OCN®, and Gregory Durm,(2) MD

Read More
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.